| Date | Title | | | Feb 09, 2010 | FDA Postpones Oncologic Drugs Advisory Committee Meeting to Review Pixantrone Due to Severe Weather Conditions| SEATTLE, Feb 09, 2010 /PRNewswire via COMTEX/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the United States Food and Drug Administration (the "FDA") informed CTI that due to severe weather conditions in the Washington, D.C. area, the FDA is postponing the Oncologic Drugs Advisory Committee ("ODAC") meeting that was to be held on Wednesday, February 10, 2010 to discuss the pixantrone New Drug Application ("NDA"). The FDA indicated that it intends to reschedule... |
|  | | Feb 08, 2010 | Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End 2009 Financial Results on February 11| SEATTLE, Feb 08, 2010 /PRNewswire via COMTEX/ -- On Thursday, February 11, 2010, at 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific, members of Cell Therapeutics, Inc.'s (CTI) (Nasdaq and MTA: CTIC) management team will host a conference call to discuss the Company's 2009 fourth quarter and year-end achievements and financial results.
Conference Call Numbers
Thursday, February 11
8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time
1-877-9... |
| | | Jan 13, 2010 | Cell Therapeutics, Inc. Announces Institutional Investors Purchase $30 Million of Preferred Stock and Warrants| SEATTLE, Jan 13, 2010 /PRNewswire via COMTEX/ -- Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) (the "Company") today announced that it has entered into an agreement to sell $30 million of shares of its Series 3 Preferred Stock and warrants to purchase shares of its common stock in a registered offering to two institutional investors. Each share of Series 3 Preferred Stock is convertible at the option of the holder, at any time during its existence, into approximately 823 shares of common stock ... |
| | | Jan 11, 2010 | Cell Therapeutics, Inc. (CTI) to Present at the 28th Annual JP Morgan Healthcare Conference| SEATTLE, Jan 11, 2010 /PRNewswire via COMTEX/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) management will present at the 28th Annual JP Morgan Healthcare Conference in San Francisco. The conference will be held January 11-14, 2010, at the Westin St. Francis. CTI will present on Thursday, January 14, 2010, 2:00 PM Pacific Time. The conference will be webcast live with slides and available for replay after the presentation. The webcast can be accessed at www.celltherapeutics.com.
... |
| |
|
